(Q26998093)

language of work or name

1 reference

November 2012

1 reference

Alimentary Pharmacology & Therapeutics

published in

1 reference

volume

36

1 reference

page(s)

815-23

1 reference

issue

9

1 reference

GI epidemiology: nonalcoholic fatty liver disease

cites work

1 reference

Review article: diagnosis and treatment of non-alcoholic fatty liver disease

21 January 2018

1 reference

Review article: hepatic steatosis and insulin resistance

21 January 2018

1 reference

Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient - death of a dogma from analysis of therapeutic studies?

21 January 2018

1 reference

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

21 January 2018

1 reference

Non-alcoholic fatty liver disease: a massive problem.

21 January 2018

1 reference

Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence

21 January 2018

1 reference

Nonalcoholic steatohepatitis: risk factors and diagnosis

21 January 2018

1 reference

Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease

21 January 2018

1 reference

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

21 January 2018

1 reference

Endpoints and clinical trial design for nonalcoholic steatohepatitis

21 January 2018

1 reference

The clinicopathologic spectrum and management of nonalcoholic fatty liver disease

21 January 2018

1 reference

Non-alcoholic fatty liver disease: an emerging pathological spectrum

21 January 2018

1 reference

The histologic spectrum of nonalcoholic fatty liver disease

21 January 2018

1 reference

The wide spectrum of steatohepatitis: a report of four cases and a review of the literature.

21 January 2018

1 reference

Nonalcoholic fatty liver disease: a review of the spectrum of disease, diagnosis, and therapy

21 January 2018

1 reference

Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research

21 January 2018

1 reference

Non-alcoholic fatty liver disease: what's new under the microscope?

21 January 2018

1 reference

Histopathology of nonalcoholic fatty liver disease

21 January 2018

1 reference

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

The epidemiology, pathogenesis and histopathology of fatty liver disease

21 January 2018

1 reference

Non-alcoholic steatohepatitis: from cell biology to clinical practice

21 January 2018

1 reference

Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis

21 January 2018

1 reference

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

21 January 2018

1 reference

Genetic factors associated with the presence and progression of nonalcoholic fatty liver disease: a narrative review.

21 January 2018

1 reference

Genetic variants in candidate genes influencing NAFLD progression

21 January 2018

1 reference

Genetics of alcoholic and nonalcoholic fatty liver disease

21 January 2018

1 reference

Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.

21 January 2018

1 reference

A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity.

21 January 2018

1 reference

Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease

21 January 2018

1 reference

The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life.

21 January 2018

1 reference

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

21 January 2018

1 reference

Adiponutrin gene is regulated by insulin and glucose in human adipose tissue.

21 January 2018

1 reference

A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans

21 January 2018

1 reference

Variation in the adiponutrin gene influences its expression and associates with obesity.

21 January 2018

1 reference

Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese

21 January 2018

1 reference

Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region

21 January 2018

1 reference

Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease.

21 January 2018

1 reference

Roles of liver innate immune cells in nonalcoholic fatty liver disease

21 January 2018

1 reference

A novel role for Hedgehog in T-cell receptor signaling: implications for development and immunity.

21 January 2018

1 reference

Sonic hedgehog signalling in T-cell development and activation

21 January 2018

1 reference

The Notch and Sonic hedgehog signalling pathways in immunity.

21 January 2018

1 reference

Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease.

21 January 2018

1 reference

Non-alcoholic steatohepatitis pathogenesis: role of repair in regulating the disease progression

21 January 2018

1 reference

Apoptosis: why and how does it occur in biology?

21 January 2018

1 reference

Mechanisms of disease progression in NASH: new paradigms

21 January 2018

1 reference

Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease

21 January 2018

1 reference

Increased production of sonic hedgehog by ballooned hepatocytes

21 January 2018

1 reference

NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease

21 January 2018

1 reference

Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.

21 January 2018

1 reference

Hepatic progenitor cells: an update

21 January 2018

1 reference

Hepatic progenitor cells in human liver diseases

21 January 2018

1 reference

Liver biopsy for histological assessment: The case against

21 January 2018

1 reference

Can NASH be diagnosed, graded, and staged noninvasively?

21 January 2018

1 reference

Noninvasive assessment of fibrosis and steatosis in NASH and ASH.

21 January 2018

1 reference

NAFLD in the absence of metabolic syndrome: different epidemiology, pathogenetic mechanisms, risk factors for disease progression?

21 January 2018

1 reference

Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis

21 January 2018

1 reference

Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications

21 January 2018

1 reference

Review article: the treatment of non-alcoholic steatohepatitis with thiazolidinediones

21 January 2018

1 reference

3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy

21 January 2018

1 reference

Review article: role of oxidative stress in the progression of non-alcoholic steatosis

21 January 2018

1 reference

Review article: Drug therapy for non-alcoholic fatty liver disease

21 January 2018

1 reference

Upregulation of hemoglobin expression by oxidative stress in hepatocytes and its implication in nonalcoholic steatohepatitis

21 January 2018

1 reference

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

21 January 2018

1 reference

Non-alcoholic steatohepatitis with normal aminotransferase values

21 January 2018

1 reference

Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels

21 January 2018

1 reference

Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease.

21 January 2018

1 reference

High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease.

21 January 2018

1 reference

Non-invasive diagnostic tests for non-alcoholic fatty liver disease

21 January 2018

1 reference

Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis

21 January 2018

1 reference

Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease

21 January 2018

1 reference